Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Pharmaceutical Business Review
Return to: PBR Home | Suppliers

DXA Services

Published 04 October 2011 | By CoreLab Partners

Dual energy X-ray absorptiometry (DXA) is an efficient, noninvasive, low-radiation dose measurement of bone mineral content (BMC), bone mineral density (BMD), and total body composition (fat and fat-free mass). It's currently the most common imaging tool used to determine BMD for disease processes such as osteoporosis. DXA offers low-radiation dosing (1/10 of the typical chest X-ray), rapid scan time, and ease of use. These distinctive attributes make DXA widely popular in the clinical research arena especially in trials employing bone density as a safety or efficacy endpoint.

As a registered user of PBR you can skip the majority of this form. Registration is FREE so register now or log in if you're already a member.
Fill In Details

Help us to better improve our communications by entering all or some of the additional fields below, then click 'Download White Paper' to be taken to the next page.




Complete a quick security check and confirm terms and conditions

This step helps prevent unfair use of automated programs.
I have read and accept the terms and conditions and privacy policy.
We'd like to keep you informed about relevant promotions, products and services, or if you would prefer not to receive these, uncheck this box.
If you would prefer not to hear from carefully selected third party companies uncheck this box



By clicking the 'download white paper' button you agree to pass your details as shown to the white paper advertiser. The enquirer also permits the advertiser to follow up the enquiry by phone or email. PBR is in no way responsible for further communication between parties.
Fields marked * are compulsory